163 related articles for article (PubMed ID: 37286891)
21. Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
Lu YS; Lien HC; Yeh PY; Yeh KH; Kuo ML; Kuo SH; Cheng AL
World J Gastroenterol; 2005 Oct; 11(40):6373-80. PubMed ID: 16419168
[TBL] [Abstract][Full Text] [Related]
22. Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.
Kerkvliet CP; Truong TH; Ostrander JH; Lange CA
Essays Biochem; 2021 Dec; 65(6):971-983. PubMed ID: 34132331
[TBL] [Abstract][Full Text] [Related]
23. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
Bilir B; Kucuk O; Moreno CS
J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
[TBL] [Abstract][Full Text] [Related]
24. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK.
Zhao M; Howard EW; Parris AB; Guo Z; Zhao Q; Yang X
Mol Carcinog; 2017 Mar; 56(3):849-862. PubMed ID: 27533114
[TBL] [Abstract][Full Text] [Related]
25. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
26. Serum/glucocorticoid-regulated kinase 1-targeted transient receptor potential oxalate subtype 1 regulates bladder smooth muscle cell proliferation due to bladder outlet obstruction in mice via activated T cell nuclear factor transcription factor 2.
He J; Yang J; Chen L; He P; Liu X; Wang K; Dong T; Li J; Ma X; Bastian A; Arnulf S
IUBMB Life; 2022 May; 74(5):463-473. PubMed ID: 35148462
[TBL] [Abstract][Full Text] [Related]
27. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
[TBL] [Abstract][Full Text] [Related]
28. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
29. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
30. PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
Noureddine LM; Ablain J; Surmieliova-Garnès A; Jacquemetton J; Pham TH; Marangoni E; Schnitzler A; Bieche I; Badran B; Trédan O; Hussein N; Le Romancer M; Poulard C
Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37536978
[TBL] [Abstract][Full Text] [Related]
31. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
32. Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling.
Wu L; Lin Y; Gao S; Wang Y; Pan H; Wang Z; Pozzolini M; Yang F; Zhang H; Yang Y; Xiao L; Xu Y
Front Pharmacol; 2023; 14():1200843. PubMed ID: 37346292
[No Abstract] [Full Text] [Related]
33. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
Lv ZD; Xin HN; Yang ZC; Wang WJ; Dong JJ; Jin LY; Li FN
J Cell Physiol; 2019 Jul; 234(7):10819-10826. PubMed ID: 30624764
[TBL] [Abstract][Full Text] [Related]
34. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
[TBL] [Abstract][Full Text] [Related]
35. The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery.
Sasaki T; Nakamura Y; Hata S; Shimada H
Anticancer Res; 2023 Jul; 43(7):2965-2974. PubMed ID: 37351994
[TBL] [Abstract][Full Text] [Related]
36. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
37. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
38. Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.
Buoso E; Ronfani M; Galasso M; Ventura D; Corsini E; Racchi M
Pharmacol Res; 2019 May; 143():17-26. PubMed ID: 30862604
[TBL] [Abstract][Full Text] [Related]
39. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid receptor and serum- and glucocorticoid-induced kinase-1 in esophageal adenocarcinoma and adjacent Barrett's esophagus.
Gokon Y; Fujishima F; Taniyama Y; Ishida H; Yamagata T; Sawai T; Uzuki M; Ichikawa H; Itakura Y; Takahashi K; Yajima N; Hagiwara M; Nishida A; Ozawa Y; Sakuma T; Sakamoto K; Zuguchi M; Saito M; Kamei T; Sasano H
Pathol Int; 2020 Jun; 70(6):355-363. PubMed ID: 32173971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
